Sign in
4/A

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001209191-22-034503

Director acquired 64,656 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Makes Brigid Director 2022-06-01 Grant or award +64,656 158,706 D
Derivatives
Makes Brigid Director 2022-06-01 Grant or award · Stock Option (Right to Buy) +100,308 194,358 D
Makes Brigid Director 2022-06-01 Grant or award · Director's Deferred Share Units +361,680 643,804 D
Loading xslF345X03/doc4a.xml…